1. Home
  2. AOSL vs ARVN Comparison

AOSL vs ARVN Comparison

Compare AOSL & ARVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alpha and Omega Semiconductor Limited

AOSL

Alpha and Omega Semiconductor Limited

HOLD

Current Price

$20.96

Market Cap

940.9M

Sector

Technology

ML Signal

HOLD

Logo Arvinas Inc.

ARVN

Arvinas Inc.

HOLD

Current Price

$12.86

Market Cap

781.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AOSL
ARVN
Founded
2000
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
940.9M
781.0M
IPO Year
2010
2018

Fundamental Metrics

Financial Performance
Metric
AOSL
ARVN
Price
$20.96
$12.86
Analyst Decision
Buy
Buy
Analyst Count
3
23
Target Price
$23.67
$18.14
AVG Volume (30 Days)
423.5K
752.6K
Earning Date
02-05-2026
02-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$685,883,000.00
$312,300,000.00
Revenue This Year
N/A
$10.55
Revenue Next Year
$6.59
N/A
P/E Ratio
N/A
N/A
Revenue Growth
2.92
93.86
52 Week Low
$15.90
$5.90
52 Week High
$42.00
$20.38

Technical Indicators

Market Signals
Indicator
AOSL
ARVN
Relative Strength Index (RSI) 41.47 49.75
Support Level $20.04 $12.90
Resistance Level $23.39 $14.00
Average True Range (ATR) 1.46 0.70
MACD -0.25 -0.05
Stochastic Oscillator 58.62 20.73

Price Performance

Historical Comparison
AOSL
ARVN

About AOSL Alpha and Omega Semiconductor Limited

Alpha & Omega Semiconductor Ltd designs, develops and supplies a portfolio of power semiconductors targeting various applications, including personal computers, flat-panel TVs, LED lighting, smartphones, battery packs, consumer and industrial motor controls and power supplies for TVs, computers, servers and telecommunications equipment. It generates revenue mainly from the sale of power semiconductors, consisting of power discretes and power ICs with a presence in Hong Kong, China, South Korea, the United States and other countries. It operates in one operating segment: the design, development and supply of power semiconductor products for computing, consumer electronics, communication and industrial applications.

About ARVN Arvinas Inc.

Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.

Share on Social Networks: